This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Poor budgeting can trigger debt spirals and eventual bankruptcy if left unchecked. Learn how disciplined budgeting helps protect assets and secure your financial future.
27,895 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Nebius stock falls 17% after revealing a ballooning debt load, undersc9oring how the neocloud trade could turn into a...
Compass International Holdings rolls out its AI-powered Home Platform across its company-owned brands, signaling a ma...
Vitalik Buterin unveiled a three- to four-year Lean Ethereum upgrade, placing ETH’s institutional appeal on a four-ye...
A late-appeal by a U.S. president over Balogun’s red card has thrown FIFA's neutrality into the spotlight, with poten...
A top Deutsche Bank economist warns that AI’s productivity gains may take years to materialize. If returns lag, risin...
Fi is rolling out a satellite-enabled dog collar that tracks pets where cell service fails, signaling a potential shi...
Credo Technology rides a surge in AI infrastructure demand, but the path to $500 by 2030 hinges on durable revenue gr...
Coinbase reports a resilient services business while MicroStrategy shoulders heavy bitcoin exposure and fixed costs a...
Romance can cloud judgment, especially in a city built on showmanship. This article breaks down how dating scams in L...
JPMorgan Chase posted a strong quarterly beat, led by a surge in equity-markets revenue and higher net interest incom...
Native american graduation rates have reached a record high, signaling progress in education and earnings potential f...